Connect with us

Business

L’Oréal Set to Acquire Medik8 in Reported €1 Billion Deal

Published

on

L’Oréal to Acquire Medik8: A Strategic Skincare Expansion

L’Oréal continues its bold expansion strategy by acquiring science-driven skincare brand Medik8. This skincare move supports L’Oréal’s premium dermatological growth goals. The agreement signals L’Oréal’s strong belief in Medik8’s research-first, results-driven philosophy and its future international success.

L’Oréal’s Strategic Move into Science-Led Skincare

L’Oréal to Acquire Medik8 marks a major step into innovative skincare. Medik8, best known for Crystal Retinal and its CSA Philosophy, emphasizes science, efficacy, and ingredient transparency. Furthermore, the company blends professional skincare roots with omni-channel reach, especially across Europe and the U.S.

Strengthening the L’Oréal Luxe Portfolio

This acquisition boosts L’Oréal’s Luxe portfolio with a proven, premium skincare player. Medik8 has thrived by combining accessibility with clinical results. It also appeals to professionals and consumers seeking real results without compromising safety.

L’Oréal to Acquire Medik8 not only secures a majority stake but also positions the French giant for deeper dermatological expansion. With brands like La Roche-Posay and Vichy already thriving, this move adds serious firepower. Medik8 will complement L’Oréal’s existing high-performance offerings.

Management Continuity and Global Potential

As part of the deal, Inflexion remains a minority shareholder, ensuring experience stays within reach. Founder Elliot Isaacs continues on the board, maintaining Medik8’s vision. Additionally, the current management team remains in place, supporting global growth initiatives.

“This is an exciting day for Medik8,” said CEO Simon Coble. “Our shared vision will bring our innovation to more people.” Cyril Chapuy of L’Oréal Luxe added, “We are thrilled to welcome Medik8, a perfect addition to our results-focused skincare brands.”

Advertisement

A Billion-Euro Deal with Global Implications

According to the Financial Times, L’Oréal agreed to acquire Medik8 for approximately EUR 1 billion. Regulatory approval is expected soon. This follows recent acquisitions like Aesop and a deeper partnership with Prada, reinforcing L’Oréal’s premium skincare focus.

Founded in 2009, Medik8 employs 300 people and manufactures its range in the UK. With Inflexion’s 2021 investment, Medik8 launched a new research centre and expanded into the U.S., paving the way for this acquisition.


Stay informed with updates on L’Oréal to Acquire Medik8, beauty industry trends, and brand acquisitions—explore more news on this website.

@2024 Copyright Grocery Agency | All rights reserved. Alphanet Web Design